Downstream processing has long been the primary bottleneck in biopharmaceutical manufacturing. While upstream titers have increased significantly over the past decade, harvesting a highly pure, stable therapeutic protein from a complex cellular soup remains a significant challenge. Among the toolkits available to downstream process engineers, affinity chromatography stands out as the gold...